Tae S. Lim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Risk of HCC in Elderly Patients With MASLD: Proposal of an Effective Surveillance Strategy.
Journal: Journal of gastroenterology and hepatology
Published: June 05, 2026
Comparable Predictive Performance of Non-VCTE-Based Machine Learning Model for HBV-Infected Hepatocellular Carcinoma Risk.
Journal: Journal of gastroenterology and hepatology
Published: February 14, 2026
Serum IGF-1 and the Risk of Cardio-Kidney Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: Diabetes, obesity & metabolism
Published: January 21, 2026
Hepatic fibro-inflammation measured by magnetic resonance imaging iron-corrected T1 predicts extrahepatic cancer risk: a UK Biobank study.
Journal: Clinical and molecular hepatology
Published: December 03, 2025
Comment on 'Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank' by T. S. Lim et al.-Authors' Reply.
Journal: Journal of cachexia, sarcopenia and muscle
Published: June 13, 2025
The Influence of Metabolic Dysfunction-Associated Steatotic Liver Disease and Body Mass Index on the Incidence of Alzheimer Disease: A Nationwide Cohort Study.
Journal: Gut and liver
Published: February 12, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated Cirrhosis.
Journal: Journal of gastroenterology and hepatology
Published: December 15, 2024
Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank.
Journal: Journal of cachexia, sarcopenia and muscle
Published: September 05, 2024
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis.
Journal: Diagnostics (Basel, Switzerland)
Published: November 01, 2022
Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis.
Journal: Hepatology (Baltimore, Md.)
Published: May 25, 2022
Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population.
Journal: Hepatology international
Published: March 31, 2022
Last Updated: 09/26/2026